Maximal Safe Resection in Glioblastoma Surgery: A Systematic Review of Advanced Intraoperative Image-Guided Techniques

Glioblastoma multiforme (GBM) represents the most common and aggressive central nervous system tumor associated with a poor prognosis. The aim of this study was to depict the role of intraoperative imaging techniques in GBM surgery and how they can ensure the maximal extent of resection (EOR) while preserving the functional outcome. The authors conducted a systematic review following PRISMA guidelines on the PubMed/Medline and Scopus databases. A total of 1747 articles were identified for screening. Studies focusing on GBM-affected patients, and evaluations of EOR and functional outcomes with the aid of advanced image-guided techniques were included. The resulting studies were assessed for methodological quality using the Risk of Bias in Systematic Review tool. Open Science Framework registration DOI 10.17605/OSF.IO/3FDP9. Eighteen studies were eligible for this systematic review. Among the selected studies, eight analyzed Sodium Fluorescein, three analyzed 5-aminolevulinic acid, two evaluated IoMRI imaging, two evaluated IoUS, and three evaluated multiple intraoperative imaging techniques. A total of 1312 patients were assessed. Gross Total Resection was achieved in the 78.6% of the cases. Follow-up time ranged from 1 to 52 months. All studies assessed the functional outcome based on the Karnofsky Performance Status scale, while one used the Neurologic Assessment in Neuro-Oncology score. In 77.7% of the cases, the functional outcome improved or was stable over the pre-operative assessment. Combining multiple intraoperative imaging techniques could provide better results in GBM surgery than a single technique. However, despite good surgical outcomes, patients often present a neurocognitive decline leading to a marked deterioration of the quality of life. Advanced intraoperative image-guided techniques can allow a better understanding of the anatomo-functional relationships between the tumor and the surrounding brain, thus maximizing the EOR while preserving functional outcomes.

[1]  K. Schebesch,et al.  Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome , 2022, Brain & spine.

[2]  M. Linxweiler,et al.  Development, Implementation and Application of Confocal Laser Endomicroscopy in Brain, Head and Neck Surgery—A Review , 2022, Diagnostics.

[3]  M. Sodeoka,et al.  Raman Spectroscopy for Chemical Biology Research , 2022, Journal of the American Chemical Society.

[4]  B. Pollo,et al.  Confocal laser imaging in neurosurgery: A comprehensive review of sodium fluorescein-based CONVIVO preclinical and clinical applications , 2022, Frontiers in Oncology.

[5]  M. Lawton,et al.  Intraoperative confocal laser endomicroscopy: prospective in vivo feasibility study of a clinical-grade system for brain tumors. , 2022, Journal of neurosurgery.

[6]  M. Ivan,et al.  Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review , 2021, Journal of Neuro-Oncology.

[7]  Bjoern H Menze,et al.  Tracking the Corticospinal Tract in Patients With High-Grade Glioma: Clinical Evaluation of Multi-Level Fiber Tracking and Comparison to Conventional Deterministic Approaches , 2021, Frontiers in Oncology.

[8]  G. Ciofani,et al.  Discrimination of glioma patient-derived cells from healthy astrocytes by exploiting Raman spectroscopy. , 2021, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[9]  G. Parla,et al.  Resting-State Functional Magnetic Resonance Imaging for Surgical Neuro-Oncology Planning: Towards a Standardization in Clinical Settings , 2021, Brain sciences.

[10]  Suneil K. Kalia,et al.  A Network-Based Approach to Glioma Surgery: Insights from Functional Neurosurgery , 2021, Cancers.

[11]  M. Borkovec,et al.  Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years , 2021, Cancers.

[12]  M. Aubry,et al.  Integration of Raman spectra with transcriptome data in glioblastoma multiforme defines tumour subtypes and predicts patient outcome , 2021, Journal of cellular and molecular medicine.

[13]  R. Fulbright,et al.  Surgical strategies for older patients with glioblastoma , 2021, Journal of Neuro-Oncology.

[14]  H. Morales Current and Future Challenges of Functional MRI and Diffusion Tractography in the Surgical Setting: From Eloquent Brain Mapping to Neural Plasticity. , 2021, Seminars in ultrasound, CT, and MR.

[15]  C. Thompson,et al.  Fluorescein-guided Resection of High Grade Gliomas: A Meta-Analysis. , 2021, World neurosurgery.

[16]  Bledi C. Brahimaj,et al.  Reducing the Cognitive Footprint of Brain Tumor Surgery , 2021, Frontiers in Neurology.

[17]  S. Luzzi,et al.  Supratentorial high-grade gliomas: maximal safe anatomical resection guided by augmented reality high-definition fiber tractography and fluorescein. , 2021, Neurosurgical focus.

[18]  P. Canoll,et al.  Rationale and Clinical Implications of Fluorescein-Guided Supramarginal Resection in Newly Diagnosed High-Grade Glioma , 2021, Frontiers in Oncology.

[19]  A. Vincent,et al.  Intraoperative B-Mode Ultrasound Guided Surgery and the Extent of Glioblastoma Resection: A Randomized Controlled Trial , 2021, Frontiers in Oncology.

[20]  V. Staartjes,et al.  Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis , 2021, Pituitary.

[21]  P. Ferroli,et al.  Confocal Laser Microscopy in Neurosurgery: State of the Art of Actual Clinical Applications , 2021, Journal of clinical medicine.

[22]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[23]  G. Umana,et al.  Brain Mapping-Aided SupraTotal Resection (SpTR) of Brain Tumors: The Role of Brain Connectivity , 2021, Frontiers in Oncology.

[24]  J. Weinberg,et al.  Intraoperative MRI for Brain Tumors , 2021, Journal of Neuro-Oncology.

[25]  R. Altieri,et al.  Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome. , 2021, Neurosurgical focus.

[26]  F. Vergani,et al.  5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma—a comparative cohort study of 343 patients , 2021, Neuro-oncology advances.

[27]  Alexander J. Schupper,et al.  The Neurosurgeon’s Armamentarium for Gliomas: An Update on Intraoperative Technologies to Improve Extent of Resection , 2021, Journal of clinical medicine.

[28]  M. Riemenschneider,et al.  Intraoperative imaging of brain tumors with fluorescein: confocal laser endomicroscopy in neurosurgery. Clinical and user experience. , 2021, Neurosurgical focus.

[29]  B. Meyer,et al.  Intraoperative MRI-based elastic fusion for anatomically accurate tractography of the corticospinal tract: correlation with intraoperative neuromonitoring and clinical status. , 2021, Neurosurgical focus.

[30]  V. Rohde,et al.  Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery. , 2021, Neurosurgical focus.

[31]  A. Golby,et al.  Intraoperative Imaging for High-Grade Glioma Surgery. , 2021, Neurosurgery clinics of North America.

[32]  P. Dolce,et al.  High Grade Glioma Treatment in Elderly People: Is It Different Than in Younger Patients? Analysis of Surgical Management Guided by an Intraoperative Multimodal Approach and Its Impact on Clinical Outcome , 2021, Frontiers in Oncology.

[33]  C. Clark,et al.  Neurosurgical applications of tractography in the UK , 2020, British journal of neurosurgery.

[34]  Cahit Kural,et al.  Fluorescein Sodium-Guided Neuroendoscopic Resection of Deep-Seated Malignant Brain Tumors: Preliminary Results of 18 Patients. , 2020, Operative neurosurgery.

[35]  N. Voets,et al.  Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced fluorescence-guided surgery. , 2020, Journal of neurosurgery.

[36]  J. Calatayud-Pérez,et al.  Glioblastoma with primitive neuronal component: A case report and considerations of fluorescence-guided surgery , 2020, Surgical neurology international.

[37]  C. Bettegowda,et al.  A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma , 2020, Journal of Neuro-Oncology.

[38]  G. Parla,et al.  Resting-State Functional Connectome in Patients with Brain Tumors Before and After Surgical Resection. , 2020, World neurosurgery.

[39]  H. Duffau,et al.  Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery , 2020, Journal of Neuro-Oncology.

[40]  A. Olivi,et al.  5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery. , 2020, Neurosurgery.

[41]  M. Berger,et al.  High Interobserver Agreement in the Subjective Classification of 5‐Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas , 2020, Lasers in surgery and medicine.

[42]  T. Schwartz,et al.  Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis. , 2020, Journal of neurosurgery.

[43]  K. Paulsen,et al.  Characterizing the heterogeneity in 5-aminolevulinic acid-induced fluorescence in glioblastoma. , 2020, Journal of neurosurgery.

[44]  S. Bhatia,et al.  Utility of sodium fluorescein for achieving resection targets in glioblastoma: increased gross- or near-total resections and prolonged survival. , 2020, Journal of neurosurgery.

[45]  G. Grasso,et al.  Magnetic resonance spectrobiopsy for prediction of isocitrate dehydrogenase mutation in glioma. , 2019, World neurosurgery.

[46]  L. Bello,et al.  Innovation in Neurosurgery: The Concept of Cognitive Mapping. , 2019, World neurosurgery.

[47]  G. Parla,et al.  Resting-State Functional Magnetic Resonance Imaging for Brain Tumor Surgical Planning: Feasibility in Clinical Setting. , 2019, World neurosurgery.

[48]  A. Sfacteria,et al.  Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology. , 2019, World neurosurgery.

[49]  Ke Zhu,et al.  Optical biopsy identification and grading of gliomas using label-free visible resonance Raman spectroscopy , 2019, Journal of biomedical optics.

[50]  W. Stummer,et al.  Markers for Identifying and Targeting Glioblastoma Cells during Surgery , 2019, Journal of Neurological Surgery Part A: Central European Neurosurgery.

[51]  K. Schaller,et al.  Navigated Intraoperative 2-Dimensional Ultrasound in High-Grade Glioma Surgery: Impact on Extent of Resection and Patient Outcome. , 2019, Operative neurosurgery.

[52]  Samuel B. Tomlinson,et al.  Innovations in the Art of Microneurosurgery for Reaching Deep-Seated Cerebral Lesions (invited submission for "Innovation in Neurosurgery" special issue). , 2019, World neurosurgery.

[53]  Jian Hong,et al.  Outcome comparisons of high-grade glioma resection with or without fluorescein sodium-guidance. , 2019, Current problems in cancer.

[54]  G. Grasso,et al.  When Neuroprotection Becomes a Potential Ally of High-Grade Glioma. , 2019, World neurosurgery.

[55]  P. Ferroli,et al.  Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme. , 2019, World neurosurgery.

[56]  V. Rizzo,et al.  Multimodal Surgical Treatment of High-Grade Gliomas in the Motor Area: The Impact of the Combination of Navigated Transcranial Magnetic Stimulation and Fluorescein-Guided Resection. , 2019, World neurosurgery.

[57]  Jing Yan,et al.  Diffusion Tensor Imaging with Fluorescein Sodium Staining in the Resection of High-Grade Gliomas in Functional Brain Areas. , 2019, World neurosurgery.

[58]  Ludovica Leone,et al.  Maximizing the Extent of Resection in High-Grade Glioma. , 2019, World neurosurgery.

[59]  M. Munari,et al.  Combined Fluorescence Using 5-Aminolevulinic Acid and Fluorescein Sodium at Glioblastoma Border: Intraoperative Findings and Histopathologic Data About 3 Newly Diagnosed Consecutive Cases. , 2019, World neurosurgery.

[60]  Walter Stummer,et al.  5-ALA and FDA approval for glioma surgery , 2019, Journal of Neuro-Oncology.

[61]  V. Rohde,et al.  Endoscopic Fluorescence-Guided Resection Increases Radicality in Glioblastoma Surgery. , 2019, Operative neurosurgery.

[62]  D. Roberts,et al.  Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma. , 2019, Journal of neurosurgery.

[63]  F. DiMeco,et al.  Advanced Ultrasound Imaging in Glioma Surgery: Beyond Gray-Scale B-mode , 2018, Front. Oncol..

[64]  Cungang Fan,et al.  Safety and feasibility of low-dose fluorescein-guided resection of glioblastoma , 2018, Clinical Neurology and Neurosurgery.

[65]  C. Catalano,et al.  Transcranial Magnetic Resonance-Guided Focused Ultrasound Surgery for Brain Tumor Ablation: Are We Ready for This Challenging Treatment? , 2018, World neurosurgery.

[66]  J. Eschbacher,et al.  Utilization of intraoperative confocal laser endomicroscopy in brain tumor surgery. , 2018, Journal of neurosurgical sciences.

[67]  M. Berger,et al.  5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas , 2018, Journal of Neuro-Oncology.

[68]  C. Hadjipanayis,et al.  Fluorescence‐guided surgery for high‐grade gliomas , 2018, Journal of surgical oncology.

[69]  R. Magge,et al.  Advances in Glioblastoma Operative Techniques. , 2018, World neurosurgery.

[70]  M. Waqas,et al.  Sodium fluorescein guided resection of malignant glioma. , 2018, JPMA. The Journal of the Pakistan Medical Association.

[71]  C. Zimmer,et al.  Setup presentation and clinical outcome analysis of treating highly language-eloquent gliomas via preoperative navigated transcranial magnetic stimulation and tractography. , 2018, Neurosurgical focus.

[72]  Guy M. McKhann,et al.  Sodium Fluorescein Facilitates Guided Sampling of Diagnostic Tumor Tissue in Nonenhancing Gliomas , 2018, Neurosurgery.

[73]  Ginu A. Thomas,et al.  Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome , 2018, Journal of Neuro-Oncology.

[74]  J. Hainfellner,et al.  Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas. , 2017, Journal of neurosurgery.

[75]  P. Ferroli,et al.  Fluorescein-Guided Surgery for Resection of High-Grade Gliomas: A Multicentric Prospective Phase II Study (FLUOGLIO) , 2017, Clinical Cancer Research.

[76]  W. Stummer,et al.  Fluorescence Imaging/Agents in Tumor Resection. , 2017, Neurosurgery clinics of North America.

[77]  G. Catapano,et al.  Fluorescein-Guided Surgery for High-Grade Glioma Resection: An Intraoperative "Contrast-Enhancer". , 2017, World neurosurgery.

[78]  Alessandro Villa,et al.  Fluorescein for resection of high-grade gliomas: A safety study control in a single center and review of the literature , 2017, Surgical neurology international.

[79]  Binsheng Zhao,et al.  Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance. , 2017, Journal of neurosurgery.

[80]  X. Armoiry,et al.  Is fluorescence-guided surgery with 5-ala in eloquent areas for malignant gliomas a reasonable and useful technique? , 2017, Neuro-Chirurgie.

[81]  W. Schwindt,et al.  Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections , 2017, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[82]  Georgios Sakas,et al.  Contrast-enhanced MR Imaging versus Contrast-enhanced US: A Comparison in Glioblastoma Surgery by Using Intraoperative Fusion Imaging. , 2017, Radiology.

[83]  Toru Iwama,et al.  Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium , 2017, Journal of Neuro-Oncology.

[84]  A. Raco,et al.  1.5-T Field Intraoperative Magnetic Resonance Imaging Improves Extent of Resection and Survival in Glioblastoma Removal. , 2017, World neurosurgery.

[85]  L. Bullinger,et al.  The patients’ view: impact of the extent of resection, intraoperative imaging, and awake surgery on health-related quality of life in high-grade glioma patients—results of a multicenter cross-sectional study , 2017, Neurosurgical Review.

[86]  Inamullah Khan,et al.  Role of Intraoperative MRI ( iMRI ) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme , 2017 .

[87]  G. Grasso Extent of Resection and Survival in Glioblastoma Multiforme. , 2016, JAMA oncology.

[88]  Dima Suki,et al.  Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. , 2016, JAMA oncology.

[89]  Michelle A. Brusatori,et al.  Shining light on neurosurgery diagnostics using Raman spectroscopy , 2016, Journal of Neuro-Oncology.

[90]  Sandy Cochran,et al.  Intraoperative Ultrasound-Guided Resection of Gliomas: A Meta-Analysis and Review of the Literature. , 2016, World neurosurgery.

[91]  D. Nandi,et al.  The use of ultrasound in intracranial tumor surgery , 2016, Acta Neurochirurgica.

[92]  Kenneth Hess,et al.  The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? , 2016, Journal of neurosurgery.

[93]  Todd Hollon,et al.  Improving the accuracy of brain tumor surgery via Raman-based technology. , 2016, Neurosurgical focus.

[94]  Luigi Solbiati,et al.  Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. , 2016, Neurosurgical focus.

[95]  Peter Nakaji,et al.  Prospective evaluation of the utility of intraoperative confocal laser endomicroscopy in patients with brain neoplasms using fluorescein sodium: experience with 74 cases. , 2016, Neurosurgical focus.

[96]  Rachel Churchill,et al.  ROBIS: A new tool to assess risk of bias in systematic reviews was developed , 2016, Journal of clinical epidemiology.

[97]  H. Steiger,et al.  Various shades of red—a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery , 2016, Neurosurgical Review.

[98]  Eduard Schreibmann,et al.  Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery , 2016, Molecular Imaging and Biology.

[99]  T. Mikkelsen,et al.  Identification of regions of normal grey matter and white matter from pathologic glioblastoma and necrosis in frozen sections using Raman imaging , 2015, Journal of Neuro-Oncology.

[100]  Fang-Cheng Yeh,et al.  High-definition fiber tractography for the evaluation of perilesional white matter tracts in high-grade glioma surgery. , 2015, Neuro-oncology.

[101]  C. Wirtz,et al.  Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival , 2015, PloS one.

[102]  S. Eljamel 5-ALA Fluorescence Image Guided Resection of Glioblastoma Multiforme: A Meta-Analysis of the Literature , 2015, International journal of molecular sciences.

[103]  J. Rutka,et al.  Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance. , 2015, Journal of neurosurgery.

[104]  G. Reifenberger,et al.  5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy , 2015, Acta Neurochirurgica.

[105]  V. Kolev,et al.  Preoperative Magnetic Resonance and Intraoperative Ultrasound Fusion Imaging for Real-Time Neuronavigation in Brain Tumor Surgery , 2014, Ultraschall in der Medizin.

[106]  C. Raftopoulos,et al.  Glioblastoma surgery with and without intraoperative MRI at 3.0T. , 2014, Neuro-Chirurgie.

[107]  Carla Richetta,et al.  Fusion imaging for intra-operative ultrasound-based navigation in neurosurgery , 2014, Journal of Ultrasound.

[108]  L. Solbiati,et al.  Intraoperative Cerebral Glioma Characterization with Contrast Enhanced Ultrasound , 2014, BioMed research international.

[109]  P. Kubben,et al.  Intraoperative magnetic resonance imaging versus standard neuronavigation for the neurosurgical treatment of glioblastoma: A randomized controlled trial , 2014, Surgical neurology international.

[110]  L. Solbiati,et al.  Intraoperative contrast-enhanced ultrasound for brain tumor surgery. , 2014, Neurosurgery.

[111]  Satoru Wada,et al.  Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma. , 2013, Journal of neurosurgery.

[112]  H. Duffau,et al.  The “onco-functional balance” in surgery for diffuse low-grade glioma: integrating the extent of resection with quality of life , 2013, Acta Neurochirurgica.

[113]  Jean-Jacques Lemaire,et al.  Intraoperative visualisation of language fascicles by diffusion tensor imaging-based tractography in glioma surgery , 2013, Acta Neurochirurgica.

[114]  Ferenc Jolesz,et al.  Neuronavigation in the surgical management of brain tumors: current and future trends , 2012, Expert review of medical devices.

[115]  K. Kallenberg,et al.  Fluorescence-Guided Operation in Recurrent Glioblastoma Multiforme Treated with Bevacizumab—Fluorescence of the Noncontrast Enhancing Tumor Tissue? , 2012, Journal of Neurological Surgery—Part A.

[116]  Guo-dong Gao,et al.  Effect of Sonographically Guided Cerebral Glioma Surgery on Survival Time , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[117]  Giuseppe Casaceli,et al.  Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgery. , 2012, Neuro-oncology.

[118]  Christopher Nimsky,et al.  Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. , 2011, Neuro-oncology.

[119]  R. Kalff,et al.  Operative treatment of subcortical metastatic tumours in the central region , 2011, Journal of Neuro-Oncology.

[120]  G. Rao,et al.  IMPACT OF INTRAOPERATIVE HIGH‐FIELD MAGNETIC RESONANCE IMAGING GUIDANCE ON GLIOMA SURGERY: A PROSPECTIVE VOLUMETRIC ANALYSIS , 2009, Neurosurgery.

[121]  G. Unsgaard,et al.  Surgical Resection of High-grade Gliomas in Eloquent Regions Guided by Blood Oxygenation Level Dependent Functional Magnetic Resonance Imaging, Diffusion Tensor Tractography, and Intraoperative Navigated 3D Ultrasound , 2009, Minimally invasive neurosurgery : MIN.

[122]  P. Willems,et al.  Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial. , 2006, Journal of neurosurgery.

[123]  Geirmund Unsgaard,et al.  Brain Operations Guided by Real-time Two-dimensional Ultrasound: New Possibilities as a Result of Improved Image Quality , 2002, Neurosurgery.

[124]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[125]  C ASSANASEN,et al.  GLIOBLASTOMA MULTIFORME. , 1965, Virginia medical monthly.